Interstitial lung disease: new challenges and evolving phenotypes

Cottin V.

Source: Eur Respir Rev 2010; 19: 91-93

Journal Issue: June 2010 - 19 (116)

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cottin V.. Interstitial lung disease: new challenges and evolving phenotypes. Eur Respir Rev 2010; 19: 91-93

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021
Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001
Interstitial lung disease: the Japanese perspective Source: International Congress 2017 – Ethnic differences and their clinical impact on respiratory diseases in Europe and Japan Year: 2017
Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016
Teleradiology in interstitial lung disease: first experiences Source: International Congress 2017 – Rare diseases Year: 2017
Treatment of interstitial lung diseases: current approaches and future directions Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019
Multidisciplinary evaluation of interstitial lung diseases: current insights Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017 Year: 2017
Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=21 Year: 2007
Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans Year: 2013
Defining severe obstructive lung disease in the biologic era: an endotype-based approach Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019 Year: 2019
The genetics of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019 Year: 2019
Childhood interstitial lung disease: A diagnostic challenge Source: International Congress 2015 – Connective tissue disorders Year: 2015
Combined emphysema & interstitial pulmonary disease. A new disease entity? Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002
Interstitial lung diseases and COVID-19: myths and reality Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021
Interstitial lung disease: improving classification and prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021
Interstitial lung diseases: course report Source: Breathe, 14 (3) 184; 10.1183/20734735.019718 Year: 2018